Profile | GDS5420 / 1556864_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 182.07 | 51 |
GSM1296119 | B_lesional_pre-dose | 137.94 | 45 |
GSM1296076 | C_lesional_pre-dose | 42.23 | 28 |
GSM1296092 | D_lesional_pre-dose | 36.24 | 28 |
GSM1296103 | E_lesional_pre-dose | 145.69 | 48 |
GSM1296078 | F_lesional_pre-dose | 9.01 | 8 |
GSM1296107 | G_lesional_pre-dose | 101.85 | 40 |
GSM1296109 | H_lesional_pre-dose | 128.3 | 44 |
GSM1296080 | I_lesional_pre-dose | 44.01 | 31 |
GSM1296090 | J_lesional_pre-dose | 10.22 | 11 |
GSM1296074 | K_lesional_pre-dose | 12.02 | 13 |
GSM1296111 | L_lesional_pre-dose | 107.11 | 40 |
GSM1296099 | M_lesional_pre-dose | 111.44 | 43 |
GSM1296086 | O_lesional_pre-dose | 35.12 | 27 |
GSM1296117 | P_lesional_pre-dose | 144.8 | 46 |
GSM1296113 | Q_lesional_pre-dose | 118.39 | 41 |
GSM1296096 | R_lesional_pre-dose | 123.49 | 45 |
GSM1296105 | S_lesional_pre-dose | 122.89 | 44 |
GSM1296098 | T_lesional_pre-dose | 268.83 | 57 |
GSM1296101 | U_lesional_pre-dose | 210.25 | 53 |
GSM1296121 | V_lesional_pre-dose | 154.54 | 48 |
GSM1296088 | W_lesional_pre-dose | 58.03 | 34 |
GSM1296082 | X_lesional_pre-dose | 39.7 | 29 |
GSM1296115 | Y_lesional_pre-dose | 88.83 | 38 |
GSM1296084 | Z_lesional_pre-dose | 86.28 | 39 |
GSM1296072 | B_lesional_day8 | 192.69 | 51 |
GSM1296069 | L_lesional_day8 | 127.64 | 42 |
GSM1296071 | P_lesional_day8 | 200.59 | 50 |
GSM1296070 | Y_lesional_day8 | 130.74 | 43 |
GSM1296073 | V_lesional_day8 | 88.05 | 39 |
GSM1296034 | A_lesional_day15 | 273.67 | 56 |
GSM1296041 | G_lesional_day15 | 108.39 | 41 |
GSM1296035 | R_lesional_day15 | 130.73 | 46 |
GSM1296038 | U_lesional_day15 | 102.92 | 42 |
GSM1296047 | B_lesional_day15 | 250.94 | 55 |
GSM1296039 | E_lesional_day15 | 108.98 | 43 |
GSM1296042 | H_lesional_day15 | 130.4 | 43 |
GSM1296043 | L_lesional_day15 | 123.05 | 42 |
GSM1296037 | M_lesional_day15 | 204.73 | 52 |
GSM1296046 | P_lesional_day15 | 180.87 | 49 |
GSM1296044 | Q_lesional_day15 | 178.53 | 48 |
GSM1296045 | Y_lesional_day15 | 135.97 | 43 |
GSM1296025 | C_lesional_day15 | 55.6 | 33 |
GSM1296033 | D_lesional_day15 | 43.82 | 30 |
GSM1296027 | I_lesional_day15 | 50.72 | 34 |
GSM1296032 | J_lesional_day15 | 54.04 | 32 |
GSM1296024 | K_lesional_day15 | 50.06 | 32 |
GSM1296031 | W_lesional_day15 | 99.44 | 40 |
GSM1296028 | X_lesional_day15 | 89.35 | 40 |
GSM1296029 | Z_lesional_day15 | 55.29 | 33 |
GSM1296026 | F_lesional_day15 | ||
GSM1296030 | O_lesional_day15 | 40.59 | 31 |
GSM1296040 | S_lesional_day15 | 123.44 | 44 |
GSM1296036 | T_lesional_day15 | 165.36 | 48 |
GSM1296048 | V_lesional_day15 | 127.48 | 44 |
GSM1296059 | A_lesional_day43 | 147.76 | 48 |
GSM1296066 | G_lesional_day43 | 122.57 | 43 |
GSM1296060 | R_lesional_day43 | 208.57 | 53 |
GSM1296063 | U_lesional_day43 | 106.65 | 42 |
GSM1296064 | E_lesional_day43 | 103.05 | 42 |
GSM1296067 | H_lesional_day43 | 205.17 | 51 |
GSM1296062 | M_lesional_day43 | 176.9 | 50 |
GSM1296068 | Q_lesional_day43 | 159.35 | 46 |
GSM1296050 | C_lesional_day43 | 103.76 | 42 |
GSM1296057 | D_lesional_day43 | 145.25 | 47 |
GSM1296052 | I_lesional_day43 | 56.24 | 35 |
GSM1296054 | J_lesional_day43 | 113.87 | 43 |
GSM1296049 | K_lesional_day43 | 121.54 | 45 |
GSM1296055 | W_lesional_day43 | 121.08 | 43 |
GSM1296053 | X_lesional_day43 | 137.09 | 46 |
GSM1296058 | Z_lesional_day43 | 99.81 | 42 |
GSM1296051 | F_lesional_day43 | 21.35 | 18 |
GSM1296056 | O_lesional_day43 | 113.72 | 45 |
GSM1296065 | S_lesional_day43 | 117 | 43 |
GSM1296061 | T_lesional_day43 | 161.82 | 48 |
GSM1296095 | A_non-lesional_pre-dose | 159.45 | 49 |
GSM1296120 | B_non-lesional_pre-dose | 190.29 | 50 |
GSM1296077 | C_non-lesional_pre-dose | 48.4 | 31 |
GSM1296093 | D_non-lesional_pre-dose | 98.91 | 40 |
GSM1296104 | E_non-lesional_pre-dose | 131.75 | 46 |
GSM1296079 | F_non-lesional_pre-dose | 78.76 | 38 |
GSM1296108 | G_non-lesional_pre-dose | 166.11 | 48 |
GSM1296110 | H_non-lesional_pre-dose | 213.87 | 51 |
GSM1296081 | I_non-lesional_pre-dose | 36.56 | 28 |
GSM1296091 | J_non-lesional_pre-dose | 73.67 | 38 |
GSM1296075 | K_non-lesional_pre-dose | 98.73 | 42 |
GSM1296112 | L_non-lesional_pre-dose | 214.04 | 51 |
GSM1296100 | M_non-lesional_pre-dose | 306.78 | 59 |
GSM1296087 | O_non-lesional_pre-dose | 27.82 | 24 |
GSM1296118 | P_non-lesional_pre-dose | 216.77 | 52 |
GSM1296114 | Q_non-lesional_pre-dose | 167 | 47 |
GSM1296097 | R_non-lesional_pre-dose | 176.87 | 50 |
GSM1296106 | S_non-lesional_pre-dose | 225.6 | 53 |
GSM1296102 | U_non-lesional_pre-dose | 266.67 | 56 |
GSM1296122 | V_non-lesional_pre-dose | 167.95 | 48 |
GSM1296089 | W_non-lesional_pre-dose | 112.67 | 42 |
GSM1296083 | X_non-lesional_pre-dose | 78.35 | 38 |
GSM1296116 | Y_non-lesional_pre-dose | 172.33 | 48 |
GSM1296085 | Z_non-lesional_pre-dose | 79.86 | 38 |